Relative Bioavailability of Early Phase and Late Phase Hetrombopag Olamine Formulations

Inclusion Criteria: 1. Sign the informed consent before the trial, and fully understand the trial content, process and possible adverse reactions; 2. Ability to complete the study as required by the protocol; 3. Healthy male or female subjects aged 18 to 45 (including 18 and 45) at the date of signing the informed consent; 4. Body mass index (BMI) within the range of 19 \~ 26 kg /m2 (including 19 and 26); Exclusion Criteria: 1. Allergic constitution; 2. History of drug use, or drug abuse screening positive; 3. Alcoholic or often drinkers; 4. History of deep vein thrombosis, or any other thromboembolic event; 5. A clear medical history of important primary organ diseases such as nervous system, cardiovascular system, urinary system, digestive system, respiratory system, metabolism and musculoskeletal system.